Apolzan, John W. http://orcid.org/0000-0001-8492-7820
LaRose, Jessica Gokee
Anton, Stephen D.
Beyl, Robbie A.
Greenway, Frank L. http://orcid.org/0000-0002-1766-6111
Wickham, Edmond P. III
Lanoye, Autumn
Harris, Melissa N.
Martin, Corby K. http://orcid.org/0000-0002-8125-4015
Bullard, Tiffany
Foster, Gary D. http://orcid.org/0000-0002-3960-0332
Cardel, Michelle I.
Funding for this research was provided by:
WW, Inc.
Article History
Received: 27 October 2022
Revised: 12 March 2023
Accepted: 27 March 2023
First Online: 6 April 2023
Competing interests
: JWA: Grants NIH NIDDK and NIMHD, NSF, and USDA. JGL: Grants NIH NIDDK. FLG: Consultant: Ed Med Resources, NovMeta Pharma, GNC, Basic Research, Scientific Advisory Board: Altimune, Pfizer, Nutraceutical Corporation, Stock/stock options: UR Labs, Plensat, Ketogenic Health Systems, Slim Health Nutrition, Energesis, Rejuvenate Bio, Patents: Melior Discoveries (Tolimidone/menthol). Grants: NovMeta Pharma. GDF: Employee and Shareholder at WW. MIC: Grants: National Institute of Health NHLBI and NIDDK. Stock/Stock Options: WW International, Inc. Employee at WW International, Inc. The authors declare no other competing interests.